Methode Electronics, Inc. Reports Fiscal 2025 Fourth Quarter and Full Year Financial Results; Board Approves Dividend

Stock Information for ABVC BioPharma Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About ABVC BioPharma Inc.

Methode Electronics to Release First Quarter Fiscal 2026 Results on Wednesday, September 3, 2025
Methode Electronics to Present at the J.P. Morgan Auto Conference
METHODE (MEI) INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Methode Electronics Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Notice to Long-Term Shareholders of Centene Corporation (NYSE: CNC); DoubleVerify Holdings, Inc. (NYSE: DV); Methode Electronics, Inc. (NYSE: MEI); and Treace Medical Concepts, Inc. (NASDAQ: TMCI); Grabar Law Office is Investigating Claims on Your Behalf
Investor Alert: Johnson Fistel Investigates Methode Electronics, Integral Ad Science, Manhattan Associates, and Crocs on Behalf of Shareholders
Methode Electronics to Release Fourth Quarter and Full Year Fiscal 2025 Results on Wednesday, July 9, 2025
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Maison Solutions Inc. (NASDAQ: MSS); Methode Electronics, Inc. (NYSE: MEI); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Xponential Fitness Inc. (NYSE: XPOF)
SHAREHOLDER ALERT: Morris Kandinov Investigating IRTC, HAYW, MEI, and MRCY; Shareholders are Encouraged to Contact the Firm

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.